engpass.radarSwiss drug shortages
Back to overview
Manufacturer

IBSA Institut Biochimique SA

3

Active shortages

70

Historical

16

Niedrig

0%

No info

Overview

IBSA Institut Biochimique SA is a pharmaceutical company whose products are distributed in Switzerland and reported via drugshortage.ch. 3 supply shortages are currently listed for this company's products. 70 historical shortages have been documented in the archive. Shortages are concentrated mainly in the ATC main groups G03 (3), M01 (2).

Reporting behaviour

Status 1 · Directly reported
3100%

Status 1 = company communicates proactively · Status 4 = no information. A high share of Status 4 raises the Severity Score.

Portfolio distribution by active substance main groups

Aggregated across 5 shortage entries for this company — grouped by ATC main group (1st hierarchy level).

G0360%
33 shortages
M0140%
22 shortages

Frequently asked questions

How frequent are supply shortages at IBSA Institut Biochimique SA?

Overall, 70 historical shortages are documented; 3 shortages are currently in the active tracker. Frequency depends heavily on the active-substance portfolio — generic-focused companies structurally have more shortages than originator companies with smaller portfolios.

Which active-substance main groups are affected at IBSA Institut Biochimique SA?

The distribution by ATC main groups is shown in the Portfolio section above. Click on any individual shortage row to see the active-substance detail page with all same-substance alternatives.

How openly does IBSA Institut Biochimique SA communicate shortages?

Reporting behaviour is visible in the "Reporting behaviour" section above (Status 1 = proactive communication, Status 4 = no information). A high share of Status 4 increases our Severity Score — methodology is linked below.

Where do I learn about IBSA Institut Biochimique SA shortages first?

The official primary source is drugshortage.ch. engpassradar.ch aggregates these notifications daily and enriches them with ODDB master data (active substance, ATC, price) and BWL mandatory-stock information. For per-substance alerts: use the Watchlist feature on the respective active-substance page.

Data from drugshortage.ch · Score methodology